The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
Arthritis Rheum. 2006 Jan;54(1):26-37. doi: 10.1002/art.21519.
Arthritis Rheum. 2006.
PMID: 16385520
Clinical Trial.